Regional Insights North America Yerba Mate Market Trends North America is set to command a considerable portion of the yerba mate market share at approximately 30% in 2026, driven by rising health consciousness, growing interest in natural energy alternatives, and successful integration into mainstream retail channels
Tariffs on pharmaceuticals can be complex
Because they influence insulin signaling, cell proliferation, and nutrient partitioning, improper dosing or stacking can lead to unwanted side effects
treat it as a baseline, not a bonus
CGRP Antibodies Developed specifically to lower the frequency of migraine attacks, the CGRP antibodies include erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab-gnlm (Emgality), and eptinezumab (Vyepti)